Kimelman & Baird’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.8M Sell
12,666
-1,992
-14% -$487K 0.23% 51
2025
Q4
$3.72M Sell
14,658
-401
-3% -$101K 0.29% 46
2025
Q3
$3.73M Sell
15,059
-343
-2% -$82.1K 0.29% 45
2025
Q2
$3.7M Sell
15,402
-64
-0.4% -$14.9K 0.3% 46
2025
Q1
$3.51M Sell
15,466
-10,207
-40% -$2.25M 0.3% 44
2024
Q4
$5.28M Sell
25,673
-3,026
-11% -$664K 0.42% 42
2024
Q3
$6.96M Sell
28,699
-708
-2% -$166K 0.56% 36
2024
Q2
$6.46M Buy
+29,407
New +$6.39M 0.53% 38
2021
Q2
$13.7M Buy
+66,395
New +$13.4M 1.22% 31

Other funds holding STE

Kimelman & Baird's STE Position: Q1 2026 in Review

Kimelman & Baird reduced its Steris (STE) stake by 14% in Q1 2026, selling an estimated $487K and leaving 12,666 shares worth $2.8M. The position accounts for 0.23% of the portfolio, ranked #51.

Kimelman & Baird first reported a position in STE in Q2 2021 and has held it in 9 quarters since. The position peaked at $13.7M in Q2 2021. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Kimelman & Baird held 12,666 shares of Steris worth $2.8M as of Q1 2026.
  • Kimelman & Baird sold 1,992 Steris shares in Q1 2026, an estimated $487K.
  • Steris made up 0.23% of Kimelman & Baird's portfolio in Q1 2026, its #51 holding.
  • Kimelman & Baird first reported a position in Steris in Q2 2021 and has held it in 9 quarters since.
  • Kimelman & Baird's Steris position peaked at $13.7M in Q2 2021.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.